Hawkins/$HWKN

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Hawkins

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.

Ticker

$HWKN
Sector
Primary listing

Industry

Chemicals

Employees

1,033

ISIN

US4202611095

Hawkins Metrics

BasicAdvanced
$2.9B
34.94
$4.03
0.86
$0.72
0.51%

What the Analysts think about Hawkins

Analyst ratings (Buy, Hold, Sell) for Hawkins stock.

Bulls say / Bears say

Hawkins, Inc. achieved record operating cash flow and, for the sixth consecutive year, record operating income, net income, diluted EPS, and adjusted EBITDA in fiscal 2024, indicating strong financial health and operational efficiency. (globenewswire.com)
The Water Treatment segment's operating income grew 69% to $53 million in fiscal 2024, driven by strategic acquisitions and expanded geographic footprint, positioning it as the company's largest reporting segment. (globenewswire.com)
Hawkins, Inc. successfully reduced its debt by $30 million in the second quarter of fiscal 2025, achieving a leverage ratio of 0.65x based on trailing proforma adjusted EBITDA, reflecting strong financial management. (investorshangout.com)
The Industrial segment experienced a 13% decrease in sales in fiscal 2024, primarily due to lower overall volumes and the divestiture of the consumer bleach packaging business, indicating potential challenges in this sector. (globenewswire.com)
The Health and Nutrition segment faced reduced sales from manufactured products amid a weaker market in the second quarter of fiscal 2025, suggesting ongoing challenges in this area. (investorshangout.com)
Hawkins, Inc. reported a 1.935% decline in revenue to $236.53 million in the second quarter of the 2024 earnings season, indicating potential challenges in maintaining revenue growth. (csimarket.com)
Data summarised monthly by Lightyear AI. Last updated on 7 Jun 2025.

Hawkins Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Hawkins Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $HWKN

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs